American Society of Transplantation and Cellular Therapy Series, 1: Enterobacterales Infection Prevention and Management after Hematopoietic Cell Transplantation.

{"article_title":"American Society of Transplantation and Cellular Therapy Series, 1: Enterobacterales Infection Prevention and Management after Hematopoietic Cell Transplantation.","author":"Satlin MJ, Weissman SJ, Carpenter PA, Seo SK, Shelburne SA","journal_title":"Transplantation and cellular therapy","issn":"2666-6367","isbn":"","publication_date":"2021-02-01","volume":"27","issue":"2","first_page":"108","page_count":"","accession_number":"33781545","doi":"10.1016\/j.jtct.2020.10.001","publisher":"Elsevier Inc","doctype":"Practice Guideline","subjects":"United States; Hematopoietic Stem Cell Transplantation adverse effects; Adult; Cell- and Tissue-Based Therapy; Child; Humans; United States","interest_area":["Infectious Disease & Vaccines"," Surgery"],"abstract":"The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to update its 2009 compendium-style infectious diseases guidelines for hematopoietic cell transplantation (HCT). A completely fresh approach was taken, with the goal of better serving clinical providers by publishing each stand-alone topic in the infectious diseases series in a concise format of frequently asked questions (FAQs), tables, and figures [1]. Adult and pediatric infectious diseases and HCT content experts developed and then answered FAQs, and then finalized topics with harmonized recommendations that were made by assigning a strength of recommendation ranging from A to E paired with a level of supporting evidence graded I to III. The first topic in the series focuses on potentially life-threatening infections in HCT caused by Enterobacterales, relevant infection risk factors, and practical considerations regarding prevention and treatment of these infections in the setting of emerging multidrug resistance. Copyright \u00a9 2020 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=33781545","isPdfLink":false,"isSAML":true,"an":"33781545","number_other":"","type_pub":"","issn_electronic":"2666-6367","languages":"English","language":"eng","date_entry":"Date Created: 20210330 Date Completed: 20210702 Latest Revision: 20231116","date_update":"20240105","titleSource":"Transplantation and cellular therapy [Transplant Cell Ther] 2021 Feb; Vol. 27 (2), pp. 108-114.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2021-02-01","description":"The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to update its 2009 compendium-style infectious diseases guidelines for hematopoietic cell transplantation (HCT). A completely fresh approach was taken, with the goal of better serving clinical providers by publishing each stand-alone topic in the infectious diseases series in a concise format of frequently asked questions (FAQs), tables, and figures [1]. Adult and pediatric infectious diseases and HCT content experts developed and then answered FAQs, and then finalized topics with harmonized recommendations that were made by assigning a strength of recommendation ranging from A to E paired with a level of supporting evidence graded I to III. The first topic in the series focuses on potentially life-threatening infections in HCT caused by Enterobacterales, relevant infection risk factors, and practical considerations regarding prevention and treatment of these infections in the setting of emerging multidrug resistance.<br \/> (Copyright © 2020 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.)","upload_link":"https:\/\/go.openathens.net\/redirector\/shalina.com?url=https:\/\/resolver.ebscohost.com\/openurl?sid=EBSCO:mdl&genre=article&issn=26666367&ISBN=&volume=27&issue=2&date=20210201&spage=108&pages=108-114&title=Transplantation and cellular therapy&atitle=American%20Society%20of%20Transplantation%20and%20Cellular%20Therapy%20Series%2C%201%3A%20Enterobacterales%20Infection%20Prevention%20and%20Management%20after%20Hematopoietic%20Cell%20Transplantation.&aulast=Satlin%20MJ&id=DOI:10.1016\/j.jtct.2020.10.001&authtype=ip,shib&custid=ns346513&groupid=main&profile=eds","no_of_pages":"","authored_by":"Satlin MJ, Weissman SJ, Carpenter PA, Seo SK, Shelburne SA"}